UniProt ID | RAB31_HUMAN | |
---|---|---|
UniProt AC | Q13636 | |
Protein Name | Ras-related protein Rab-31 | |
Gene Name | RAB31 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 194 | |
Subcellular Localization |
Golgi apparatus, trans-Golgi network . Golgi apparatus, trans-Golgi network membrane Lipid-anchor Cytoplasmic side . Early endosome . Cytoplasmic vesicle, phagosome . Cytoplasmic vesicle, phagosome membrane Lipid-anchor Cytoplasmic side . Rap |
|
Protein Description | The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. Required for the integrity and for normal function of the Golgi apparatus and the trans-Golgi network. Plays a role in insulin-stimulated translocation of GLUT4 to the cell membrane. Plays a role in M6PR transport from the trans-Golgi network to endosomes. Plays a role in the internalization of EGFR from the cell membrane into endosomes. Plays a role in the maturation of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis.. | |
Protein Sequence | MAIRELKVCLLGDTGVGKSSIVCRFVQDHFDHNISPTIGASFMTKTVPCGNELHKFLIWDTAGQERFHSLAPMYYRGSAAAVIVYDITKQDSFYTLKKWVKELKEHGPENIVMAIAGNKCDLSDIREVPLKDAKEYAESIGAIVVETSAKNAINIEELFQGISRQIPPLDPHENGNNGTIKVEKPTMQASRRCC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Ubiquitination | MAIRELKVCLLGDTG CCCCEEEEEEECCCC | 4.32 | 29967540 | |
14 | Phosphorylation | KVCLLGDTGVGKSSI EEEEECCCCCCCHHH | 31.78 | - | |
19 | Phosphorylation | GDTGVGKSSIVCRFV CCCCCCCHHHHHHHH | 21.26 | - | |
20 | Phosphorylation | DTGVGKSSIVCRFVQ CCCCCCHHHHHHHHH | 23.64 | - | |
35 | Phosphorylation | DHFDHNISPTIGASF HHCCCCCCCCCCCCE | 22.70 | 11784320 | |
36 | Phosphorylation | HFDHNISPTIGASFM HCCCCCCCCCCCCEE | 25.00 | 20230923 | |
37 | Phosphorylation | FDHNISPTIGASFMT CCCCCCCCCCCCEEC | 25.83 | 30266825 | |
41 | Phosphorylation | ISPTIGASFMTKTVP CCCCCCCCEECCCCC | 15.44 | 23403867 | |
44 | Phosphorylation | TIGASFMTKTVPCGN CCCCCEECCCCCCCC | 22.89 | 23403867 | |
61 | Phosphorylation | HKFLIWDTAGQERFH EEEEEEECCCCHHHH | 20.07 | 26074081 | |
69 | Phosphorylation | AGQERFHSLAPMYYR CCCHHHHHHCCCCCC | 24.42 | 26074081 | |
74 | Phosphorylation | FHSLAPMYYRGSAAA HHHHCCCCCCCCCEE | 6.75 | 26074081 | |
75 | Phosphorylation | HSLAPMYYRGSAAAV HHHCCCCCCCCCEEE | 11.40 | 26074081 | |
78 | Phosphorylation | APMYYRGSAAAVIVY CCCCCCCCCEEEEEE | 13.02 | 26074081 | |
85 | Phosphorylation | SAAAVIVYDITKQDS CCEEEEEEECCCCCC | 7.18 | 26074081 | |
88 | Phosphorylation | AVIVYDITKQDSFYT EEEEEECCCCCCHHH | 21.54 | 26074081 | |
98 | Ubiquitination | DSFYTLKKWVKELKE CCHHHHHHHHHHHHH | 61.40 | 29967540 | |
123 | Phosphorylation | AGNKCDLSDIREVPL ECCCCCHHHHCCCCH | 20.10 | 26091039 | |
136 | Phosphorylation | PLKDAKEYAESIGAI CHHHHHHHHHHHCEE | 18.24 | 19835603 | |
137 | Phosphorylation | LKDAKEYAESIGAIV HHHHHHHHHHHCEEE | 12.73 | - | |
139 | Phosphorylation | DAKEYAESIGAIVVE HHHHHHHHHCEEEEE | 20.39 | 19835603 | |
140 | Phosphorylation | AKEYAESIGAIVVET HHHHHHHHCEEEEEC | 3.04 | - | |
147 | Phosphorylation | IGAIVVETSAKNAIN HCEEEEECCCCCCCC | 23.52 | 26126808 | |
148 | Phosphorylation | GAIVVETSAKNAINI CEEEEECCCCCCCCH | 24.60 | 26126808 | |
163 | Phosphorylation | EELFQGISRQIPPLD HHHHHHHHCCCCCCC | 25.59 | 21712546 | |
164 | Phosphorylation | ELFQGISRQIPPLDP HHHHHHHCCCCCCCC | 36.21 | - | |
179 | Phosphorylation | HENGNNGTIKVEKPT CCCCCCCCEEECCCC | 21.54 | 24719451 | |
180 | Phosphorylation | ENGNNGTIKVEKPTM CCCCCCCEEECCCCC | 5.08 | 24719451 | |
190 | Phosphorylation | EKPTMQASRRCC--- CCCCCHHHHCCC--- | 11.90 | 24114839 | |
193 | Geranylgeranylation | TMQASRRCC------ CCHHHHCCC------ | 2.91 | - | |
194 | Geranylgeranylation | MQASRRCC------- CHHHHCCC------- | 6.23 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RAB31_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RAB31_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAB31_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RAB8A_HUMAN | RAB8A | physical | 22939629 | |
STX7_HUMAN | STX7 | physical | 22939629 | |
RAE2_HUMAN | CHML | physical | 26186194 | |
RAE1_HUMAN | CHM | physical | 26186194 | |
RB22A_HUMAN | RAB22A | physical | 26186194 | |
GDIB_HUMAN | GDI2 | physical | 26186194 | |
GDS1_HUMAN | RAP1GDS1 | physical | 26186194 | |
PGTB2_HUMAN | RABGGTB | physical | 26186194 | |
PGTA_HUMAN | RABGGTA | physical | 26186194 | |
TRIM4_HUMAN | TRIM4 | physical | 26186194 | |
RAB5A_HUMAN | RAB5A | physical | 26186194 | |
RAE2_HUMAN | CHML | physical | 28514442 | |
RAE1_HUMAN | CHM | physical | 28514442 | |
GDIA_HUMAN | GDI1 | physical | 28514442 | |
TRIM4_HUMAN | TRIM4 | physical | 28514442 | |
RB22A_HUMAN | RAB22A | physical | 28514442 | |
PGTA_HUMAN | RABGGTA | physical | 28514442 | |
PGTB2_HUMAN | RABGGTB | physical | 28514442 | |
GDIB_HUMAN | GDI2 | physical | 28514442 | |
EGFR_HUMAN | EGFR | physical | 19725050 | |
EEA1_HUMAN | EEA1 | physical | 19725050 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY. |